JOURNAL OF CHEMICAL RESEARCH 2010 567
(t, J = 7.5 Hz, 3H). Anal. Calcd for C33H25N3: C, 85.50; H, 5.44; N,
9.06. Found: C, 85.40; H, 5.52; N, 9.12%.
3-Cyano-2-(1H-indol-3-yl)-4-(2-naphthyl)-6-phenylpyridine (4h):
Pale yellow powder. IR (KBr) ν 3438, 3058, 2920, 2217, 1599, 1534,
1
1456, 1436, 1425 cm−1. H NMR (500 MHz, DMSO-d6): δ 11.86 (s,
3-Cyano-2-(2-methyl-1H-indol-3-yl)-4-(2-naphthyl)-6-(4-ethylphenyl)
pyridine (4c): Pale yellow powder. IR (KBr) ν 3393, 3054, 2963,
2361, 2217, 1568, 1522, 1459 cm−1. 1H NMR (500 MHz, DMSO-d6):
δ 11.63 (s, 1H), 8.43 (s, 1H), 8.26 (d, J = 8.0 Hz, 2H), 8.18 (s, 1H),
8.16 (d, J = 8.5 Hz, 1H), 8.12−8.06 (m, 2H), 7.98−7.96 (m, 1H), 7.72
(d, J = 8.0 Hz, 1H ), 7.66−7.65 (m, 2H), 7.42 (t, J = 8.0 Hz, 3H),
7.17−7.10 (m, 2H), 2.71−2.69 (m, 2H), 2.64 (s, 3H), 1.24 (t, J = 7.5
Hz, 3H). Anal. Calcd for C33H25N3: C, 85.50; H, 5.44; N, 9.06. Found:
C, 85.59; H, 5.38; N, 9.10%.
3-Cyano-2-(2-methyl-1H-indol-3-yl)-4-(2-naphthyl)-6-(4-ethylphenyl)
pyridine (4d): Pale yellow powder. IR (KBr) ν 3303, 3056, 2965,
2362, 2215, 1565, 1548, 1503, 1440 cm−1. 1H NMR (500 MHz,
DMSO-d6): δ 11.83 (s, 1H), 8.39 (d, J = 3.0 Hz, 2H), 8.30 (d, J = 8.5
Hz, 2H), 8.26 (d, J = 8.0 Hz, 1H), 8.15 (d, J = 8.5 Hz, 1H), 8.10−8.06
(m, 2H), 8.05 (s, 1H), 7.94 (dd, J = 8.5 Hz and J = 1.5 Hz, 1H ),
7.68−7.64 (m, 2H), 7.45 (d, J = 8.0 Hz, 2H), 7.15 (t, J = 7.5 Hz, 1H),
7.06 (d, J = 7.0 Hz, 1H), 2.72−2.71 (m, 2H), 2.56 (m, 3H), 1.25 (t,
J = 7.5 Hz, 3H). Anal. Calcd for C33H25N3: C, 85.50; H, 5.44; N, 9.06.
Found: C, 85.38; H, 5.46; N, 9.15%.
3-Cyano-2-(2-phenyl-1H-indol-3-yl)-4-(2-naphthyl)-6-(4-ethylphenyl)
pyridine (4e): Pale yellow powder. IR (KBr) ν 3348, 3057, 2964,
2362, 2336, 2214, 1562, 1535, 1501, 1455 cm−1. 1H NMR (500 MHz,
DMSO-d6): δ 12.01 (s, 1H), 8.24 (s, 1H), 8.21 (s, 1H), 8.14 (d, J = 8.5
Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H), 8.02 (t, J = 7.5 Hz, 2H), 7.74 (d,
J = 8.5 Hz, 2H), 7.65−7.62 (m, 2H), 7.55−7.42 (m, 6H), 7.36 (d,
J = 8.5 Hz, 2H), 7.26 (t, J = 7.5 Hz, 1H), 7.17 (t, J = 7.0 Hz, 1H),
2.71−2.68 (m, 2H), 1.22 (t, J = 7.5 Hz, 3H). Anal. Calcd for C38H27N3:
C, 86.83; H, 5.18; N, 7.99. Found: C, 86.91; H, 5.12; N, 7.92%.
3-Cyano-2-(5-bromo-1H-indol-3-yl)-4-(2-naphthyl)-6-(4-ethylphenyl)
pyridine (4f): Pale yellow powder. IR (KBr) ν 3335, 2970, 2919,
2360, 2215, 1576, 1566, 1532, 1508, 1441 cm−1. 1H NMR (500 MHz,
DMSO-d6): δ 12.04 (s, 1H), 8.68 (d, J = 2.0 Hz, 1H), 8.50 (d, J = 3.0
Hz, 1H), 8.39 (d, J = 2.5 Hz, 1H), 8.29 (d, J = 8.0 Hz, 2H), 8.15 (d,
J = 9.0 Hz, 1H), 8.10−8.06 (m, 3H), 7.93 (dd, J = 8.5 Hz and J = 2.0
Hz, 1H), 7.67−7.65 (m, 2H), 7.55 (d, J = 9.0 Hz, 1H), 7.45 (d, J = 8.5
Hz, 2H), 7.40 (dd, J = 8.5 Hz and J = 2.0 Hz, 1H), 2.74−2.71 (m, 2H),
1.25 (t, J = 7.5 Hz, 3H). Anal. Calcd for C32H22N3Br: C, 72.73;
H, 4.20; N, 7.95. Found: C, 72.80; H, 4.18; N, 7.83%.
3-Cyano-2-(5-methoxyl-1H-indol-3-yl)-4-(2-naphthyl)-6-(4-ethylphenyl)
pyridine (4g): Pale yellow powder. IR (KBr) ν 3295, 2964, 2361,
2216, 1565, 1506, 1535, 1437 cm−1. 1H NMR (500 MHz, DMSO-d6):
δ 11.74 (s, 1H), 8.43 (d, J = 3.0 Hz, 1H), 8.37 (s, 1H), 8.36 (s, 1H),
8.35 (s, 1H), 8.16 (s, 1H), 8.14−8.13 (t, J = 2.5 Hz, 1H), 8.10−8.06 (m,
2H), 8.03 (s, 1H), 7.92 (dd, J = 6.5 Hz and J = 2.0 Hz, 1H ), 7.67−7.65
(m, 2H), 7.47−7.43 (m, 3H), 6.91 (dd, J = 8.5 Hz and J = 2.5 Hz, 1H
), 3.85 (s, 3H), 2.72−2.71 (m, 2H), 1.25 (t, J = 7.5 Hz, 3H). Anal.
Calcd for C33H25N3O: C, 82.65; H, 5.25; N, 8.76. Found: C, 82.55;
H, 5.28; N, 8.82%.
1H), 8.47−8.43 (m, 2H), 8.41−8.38 (m, 3H), 8.16 (d, J = 8.5 Hz, 1H),
8.10−8.05 (m, 3H), 7.95 (dd, J = 8.5 Hz and J = 1.5 Hz, 1H), 7.67−7.56
(m, 6H), 7.30−7.24 (m, 2H). Anal. Calcd for C30H19N3: C, 85.49; H,
4.54; N, 9.97. Found: C, 85.58; H, 4.60; N, 10.09%.
3-Cyano-2-(1H-indol-3-yl)-4-(2-naphthyl)-6-[4-(4-propylcyclohexanyl)
phenyl]pyridine (4i): Pale yellow powder. IR (KBr) ν 3329, 3057,
2948, 2917, 2215, 1560, 1532, 1457, 1439 cm−1. 1H NMR (500 MHz,
DMSO-d6): δ 11.84 (s, 1H), 8.44 (d, J = 7.0 Hz, 1H), 8.41 (d, J = 3.0
Hz, 1H), 8.39 (s, 1H), 8.28 (d, J = 8.0 Hz, 2H), 8.15 (d, J = 8.5 Hz,
1H), 8.10−8.05 (m, 2H), 8.03(s, 1H), 7.93 (dd, J = 8.5 Hz and J = 2.0
Hz, 1H), 7.67−7.63 (m, 2H), 7.56 (d, J = 7.5 Hz, 1H), 7.45 (d, J = 8.5
Hz, 2H), 7.27−7.22 (m, 2H), 2.60−2.53 (m, 1H), 1.85 (t, J = 10.0 Hz,
4H), 1.51−1.49 (m, 2H), 1.34−1.30 (m, 3H), 1.22−1.19 (m, 2H),
1.07−1.05 (m, 2H), 0.88 (t, J = 7.0 Hz, 3H). Anal. Calcd for C39H35N3:
C, 85.84; H, 6.46; N, 7.70. Found: C, 85.76; H, 6.37; N, 7.82%
Received 16 June 2010; accepted 24 August 2010.
Paper 1000205 doi: 10.3184/030823410X12863016030919
Published online: 22 October 2010
References
1
2
3
4
5
6
A. Strecker, Liebigs Ann. Chem., 1850, 75, 27.
S.L. Cui, X.F. Lin and Y.G. Wang, J. Org. Chem., 2005, 70, 2866.
V.A. Orru Romano and D.G. Michiel, Synthesis, 2003, 1471.
L. Weber, K. Illgen and M. Almstetter, Synlett, 1999, 366.
L. Weber, Curr. Med. Chem., 2002, 9, 2085.
N.M. Evdokimov, I.V. Magedov, A.S. Kireev and A. Kornienko, Org. Lett.,
2006, 8, 899.
7
8
9
M.C. Bagley, J.W. Cale and J. Bower, Chem. Commun., 2002, 1682.
D. Dallinger, N.Y. Gorobets and C.O. Kappe, Org. Lett., 2003, 5, 1205.
P. Borgna, M. Pregnolato, I.A. Gamba and G. Mellerio, J. Heterocyclic
Chem., 1993, 30, 1079.
10 M.S.M. Carla, M.R.S.A. Carlos, R.R. Carlos and J.B. Eliezer, J. Molec.
Struct. (Theochem), 2002, 579, 31.
11 K. Poreba, A. Opolski and J. Wietrzyk, Acta Pol. Pharm., 2002, 59, 215.
12 S.C. Kuo, L.J. Huang and H. Nakamura, J. Med. Chem., 1984, 27, 539.
13 W.N. Xiong, C.G. Yang and B. Jiang, Bioorg. Med. Chem., 2001, 9, 1773.
14 L.H. Franco, E.B.K. Joffe, L. Puricelly, M. Tatian, A.M. Seldes and J.A.
Palermo, J. Nat. Prod., 1998, 61, 1130.
15 S.L. Zhu, S.J. Ji, X.M. Su, C. Sun and Y. Liu , Tetrahedron Lett., 2008, 49,
1777.
16 P. Thirumurugan and P.T. Perumal., Tetrahedron, 2009, 65, 7620.
17 P. Thirumurugan and P.T. Perumal, Tetrahedron Lett., 2009, 50, 4145.
18 S.L. Zhu, S.J. Ji, K. Zh and Y. Liu, Tetrahedron Lett., 2008, 49, 2578.
19 C. Mauricio, S. Macarena and F. Gabriela, Bioorg. Med. Chem., 2007, 15,
3356.
20 J. Slatt, I. Romero and J. Bergman, Synthesis, 2004, 2760.